The inhibitory Smad6 and Smad7 are responsible for cross-talk between TGF-β/bone morphogenic protein (BMP) signaling and other cellular signaling pathways, as well as negative feedback on their ...

The SMAD6 mutation in the children with craniosynostosis prevented proper inhibition of bone formation in the skull, leading to early skull fusion. However, since other participants with the same ...